AR113949A1 - Oligonucleótidos inmunoestimulantes - Google Patents
Oligonucleótidos inmunoestimulantesInfo
- Publication number
- AR113949A1 AR113949A1 ARP180103670A ARP180103670A AR113949A1 AR 113949 A1 AR113949 A1 AR 113949A1 AR P180103670 A ARP180103670 A AR P180103670A AR P180103670 A ARP180103670 A AR P180103670A AR 113949 A1 AR113949 A1 AR 113949A1
- Authority
- AR
- Argentina
- Prior art keywords
- oligonucleotides
- methods
- immunostimulating oligonucleotides
- immunostimulating
- immunostimulatory
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title abstract 3
- 230000003308 immunostimulating effect Effects 0.000 title abstract 3
- 102000008235 Toll-Like Receptor 9 Human genes 0.000 abstract 2
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporcionan composiciones y métodos para estimular el receptor tipo toll 9 (TLR9). En particular, en la presente se divulgan oligonucleótidos inmunoestimulantes, métodos para potenciar las propiedades inmunoestimulantes de los oligonucleótidos y métodos para provocar respuestas inmunitarias.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17207740 | 2017-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR113949A1 true AR113949A1 (es) | 2020-07-01 |
Family
ID=60888172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180103670A AR113949A1 (es) | 2017-12-15 | 2018-12-14 | Oligonucleótidos inmunoestimulantes |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR113949A1 (es) |
-
2018
- 2018-12-14 AR ARP180103670A patent/AR113949A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020001560A1 (es) | Oligonucleótidos inmunoestimulantes. | |
| ZA201903620B (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof | |
| MX2024010239A (es) | Receptores de antigenos quimericos dirigidos a bcma y metodos de uso de estos. | |
| MX2020004600A (es) | Constructos de oligonucleotidos y usos de estos. | |
| PT3585803T (pt) | Formulações de vacina pneumocócica conjugada | |
| MX2016009862A (es) | Conjugados de anticuerpo-farmaco hidrofilicos. | |
| MX2016014247A (es) | Conjugados de anticuerpo-farmaco anti-proteina tirosina quinasa 7 (anti-ptk7). | |
| MX382791B (es) | Conjugados novedosos de glicano y uso de los mismos | |
| DOP2016000223A (es) | Plásmidos inmunoestimuladores | |
| BR112017005524A2 (pt) | segmentos de rna viral como agentes imunomoduladores e componentes de vacina | |
| WO2016179034A3 (en) | Methods and compositions for stimulating immune response using potent immunostimulatory rna motifs | |
| HK1250637A1 (zh) | 用於引发免疫应答的剂和组合物 | |
| CY1125699T1 (el) | Συνθεσεις mycoplasma bovis | |
| AR113949A1 (es) | Oligonucleótidos inmunoestimulantes | |
| MX2020001954A (es) | Composiciones para el cuidado bucal y sus usos. | |
| CR20200262A (es) | Oligonucleótidos inmunoestimulantes | |
| TH2001003352A (th) | โอลิโกนิวคลีโอไทด์ที่กระตุ้นภูมิคุ้มกัน | |
| AR113950A1 (es) | Composiciones inmunoestimulantes | |
| TH2001003350A (th) | โอลิโกนิวคลีโอไทด์ที่กระตุ้นระบบภูมิคุ้มกัน | |
| MX2018003317A (es) | Celulas t modificadas que tienen propiedades anti-fuctacticas y sus usos. |